AbbVie Inc. revenue for the last year amounted to 56.33 B USD, the most of which — 26.68 B USD — came from its highest performing source at the moment, Immunology, the year earlier bringing 26.14 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought AbbVie Inc. 43.03 B USD, and the year before that — 41.88 B USD.